Prescription Medicines
KD Multivita Inj.
- Product Category
- complex vitamin injection
- Active Ingredients
- Ascorbic acid, retinol palmitate, ergocalciferol, thiamine hydrochloride, riboflavin phosphate sodium, pyridoxine hydrochloride, nicotinic acid amide, D-panthenol, tocopherol acetate, biotin, folic acid, cyanocobalamin
- Appearance
- A lyophilized injection in an amber vial containing a yellow solid cake.
01 / 02
1. Composition and Strength
1 vial
- Active ingredients:
Ascorbic acid (KP) ................................... 100 mg
Retinol Palmitate (USP) ................ 1.815mg (3,300IU as Vitamin A)
Ergocalciferol (KP) ................ 5㎍ (200IU as vitamin D)
Thiamine hydrochloride (KP) ................................ 3.81mg
Riboflavin phosphate sodium (KP) .... 3.6mg
Pyridoxine hydrochloride (KP) ...................... 4.86mg
Nicotinamide (KP) ................................ 40mg
D-Panthenol (USP) ................................. 15mg
Tocopherol acetate (KP) ...................... 10mg
Biotin (USP) ............................................ 60㎍
Folic acid (KP) .................................... 400 μg
Cyanocobalamin (KP) ................................ 5㎍
- Additives (excipients): D-mannitol ............ 400mg
-Other additives: sodium hydroxide, polysorbate 20, polysorbate 80
2. Effectiveness
1. Vitamin maintenance therapy for patients receiving nutrition through intravenous fluids
2. Prevention of vitamin (except vitamin K) deficiency in the following patients:
- During surgical operations, severe burns, fractures and other trauma
- Severe infection, coma
3. Dosage and dosage
Children and adults over 11 years of age: Gently shake 5 mL of distilled water for injection to dissolve this drug, then mix with 500 to 1,000 mL of intravenous glucose injection, saline injection, or similar infusion solution and inject intravenously once a day within 5 minutes.
4. Precautions for use
1. Warning
If more than 5,000 IU of vitamin A (retinol) is administered to a pregnant woman per day, there is a risk of causing congenital malformations. Therefore, do not administer more than 5,000 IU of vitamin A per day to women who are within 3 months of pregnancy or who may be pregnant (excluding patients with vitamin A deficiency).
2. Do not administer to the following patients.
1) Patients with hypersensitivity to this drug or its ingredients
2) Hemophilia patients (bleeding time is prolonged by dexpanthenol)
3. Administer with caution to the following patients.
1) Patients with hypercalcemia: There is a risk that hypercalcemia may worsen due to the vitamin D contained in this drug, so if any abnormalities are found after conducting a blood and urine test, discontinue administration.
2) Patients with renal impairment: Be careful about overdosing on vitamin D as there is a risk of renal function decreasing again due to the increase in blood calcium concentration caused by the vitamin D contained in this drug.
3) Children (age 11 or older)
4) Patients whose parents or siblings have a constitution that is prone to allergies such as bronchial asthma, rashes, and urticaria
5) Patients with a history of drug hypersensitivity reaction
4. Adverse reactions
1) Overdosage may cause hypersensitivity to vitamins A and D.
2) Shock and anaphylactoid symptoms: As shock and anaphylactoid symptoms may occur, observe thoroughly. If lowered blood pressure, impaired consciousness, difficulty breathing, cyanosis, nausea, chest discomfort, facial flushing, itching, sweating, etc. occur, stop immediately and take appropriate measures.
5. General precautions
If administered for more than several weeks, check for accumulation of vitamins A and D.
6. Interaction
1) Do not mix with acetazolamide, sodium chlorothiazide, tetracycline hydrochloride, and alkaline solutions.
2) There are reports that folic acid is unstable in the presence of calcium salts.
3) Some of the vitamins in this medicine may react with vitamin K.
4) The effectiveness of levodopa is reduced due to the pyridoxine hydrochloride contained in this medicine.
5) Do not use after diluting in lipid rehydration solution.
7. Administration to pregnant and lactating women
1) There is an epidemiological study conducted overseas that shows an increase in malformations centered on the hindbrain (the part formed by expansion of the lumen of the neural tube in the early stages of embryonic development) in children born to women who consumed more than 10,000 IU of vitamin A per day from the 3 months before pregnancy to the first 3 months of pregnancy. Therefore, when administering to women who are within 3 months of pregnancy or who may be pregnant, Pay attention to Dosage and Administration, and exercise appropriate caution, such as ensuring that vitamin A administration with this drug remains below 5,000 IU per day.
2) Pregnant women, women who are likely to become pregnant, and lactating women require an excessive amount of vitamins compared to the general population, but since excessive amounts may occur, it is advisable to administer them carefully according to the standards to avoid overdosing.
8. Administration to children
Efficacy and safety in children under 11 years of age have not been established.
9. Administration to elderly people
In general, elderly people have reduced physiological function, so they should be careful about reducing their intake.
10. Effect on clinical test values
1) It may interfere with the detection of urine sugar.
2) Various urinalysis (occult blood, bilirubin, nitrite) and fecal occult blood reaction tests may show false negative reactions.
3) It may turn urine yellow and affect clinical test values.
11. Application precautions
1) Injections containing this medicine should be used immediately.
2) Use immediately after opening and do not use anything left after use. Also, discard the used container.
3) Be careful when mixing as decomposition of vitamins may be accelerated.
4) Vitamins A, D, and riboflavin are sensitive to light, so minimize exposure to light, such as by using a light blocking cover.
5) Do not inject the undiluted solution as it may cause dizziness or fainting.
6) If mixed in protein amino acid preparation (transfusion solution), use within 8 hours.
12. Precautions for storage and handling
1) Store out of reach of children.
2) Avoid freezing and store in a cool place, protected from light.
3) Taking medicine out of its original container and storing it in another container may cause accidents due to misuse of the medicine or cause a decrease in the quality of the medicine, so put it in the original container and keep it tightly closed.
5. How to save
Sealed container, stored at room temperature (1~30℃)
6. Packaging unit
10 vials/case
7. Period of use
36 months from date of manufacture
1 vial
- Active ingredients:
Ascorbic acid (KP) ................................... 100 mg
Retinol Palmitate (USP) ................ 1.815mg (3,300IU as Vitamin A)
Ergocalciferol (KP) ................ 5㎍ (200IU as vitamin D)
Thiamine hydrochloride (KP) ................................ 3.81mg
Riboflavin phosphate sodium (KP) .... 3.6mg
Pyridoxine hydrochloride (KP) ...................... 4.86mg
Nicotinamide (KP) ................................ 40mg
D-Panthenol (USP) ................................. 15mg
Tocopherol acetate (KP) ...................... 10mg
Biotin (USP) ............................................ 60㎍
Folic acid (KP) .................................... 400 μg
Cyanocobalamin (KP) ................................ 5㎍
- Additives (excipients): D-mannitol ............ 400mg
-Other additives: sodium hydroxide, polysorbate 20, polysorbate 80
2. Effectiveness
1. Vitamin maintenance therapy for patients receiving nutrition through intravenous fluids
2. Prevention of vitamin (except vitamin K) deficiency in the following patients:
- During surgical operations, severe burns, fractures and other trauma
- Severe infection, coma
3. Dosage and dosage
Children and adults over 11 years of age: Gently shake 5 mL of distilled water for injection to dissolve this drug, then mix with 500 to 1,000 mL of intravenous glucose injection, saline injection, or similar infusion solution and inject intravenously once a day within 5 minutes.
4. Precautions for use
1. Warning
If more than 5,000 IU of vitamin A (retinol) is administered to a pregnant woman per day, there is a risk of causing congenital malformations. Therefore, do not administer more than 5,000 IU of vitamin A per day to women who are within 3 months of pregnancy or who may be pregnant (excluding patients with vitamin A deficiency).
2. Do not administer to the following patients.
1) Patients with hypersensitivity to this drug or its ingredients
2) Hemophilia patients (bleeding time is prolonged by dexpanthenol)
3. Administer with caution to the following patients.
1) Patients with hypercalcemia: There is a risk that hypercalcemia may worsen due to the vitamin D contained in this drug, so if any abnormalities are found after conducting a blood and urine test, discontinue administration.
2) Patients with renal impairment: Be careful about overdosing on vitamin D as there is a risk of renal function decreasing again due to the increase in blood calcium concentration caused by the vitamin D contained in this drug.
3) Children (age 11 or older)
4) Patients whose parents or siblings have a constitution that is prone to allergies such as bronchial asthma, rashes, and urticaria
5) Patients with a history of drug hypersensitivity reaction
4. Adverse reactions
1) Overdosage may cause hypersensitivity to vitamins A and D.
2) Shock and anaphylactoid symptoms: As shock and anaphylactoid symptoms may occur, observe thoroughly. If lowered blood pressure, impaired consciousness, difficulty breathing, cyanosis, nausea, chest discomfort, facial flushing, itching, sweating, etc. occur, stop immediately and take appropriate measures.
5. General precautions
If administered for more than several weeks, check for accumulation of vitamins A and D.
6. Interaction
1) Do not mix with acetazolamide, sodium chlorothiazide, tetracycline hydrochloride, and alkaline solutions.
2) There are reports that folic acid is unstable in the presence of calcium salts.
3) Some of the vitamins in this medicine may react with vitamin K.
4) The effectiveness of levodopa is reduced due to the pyridoxine hydrochloride contained in this medicine.
5) Do not use after diluting in lipid rehydration solution.
7. Administration to pregnant and lactating women
1) There is an epidemiological study conducted overseas that shows an increase in malformations centered on the hindbrain (the part formed by expansion of the lumen of the neural tube in the early stages of embryonic development) in children born to women who consumed more than 10,000 IU of vitamin A per day from the 3 months before pregnancy to the first 3 months of pregnancy. Therefore, when administering to women who are within 3 months of pregnancy or who may be pregnant, Pay attention to Dosage and Administration, and exercise appropriate caution, such as ensuring that vitamin A administration with this drug remains below 5,000 IU per day.
2) Pregnant women, women who are likely to become pregnant, and lactating women require an excessive amount of vitamins compared to the general population, but since excessive amounts may occur, it is advisable to administer them carefully according to the standards to avoid overdosing.
8. Administration to children
Efficacy and safety in children under 11 years of age have not been established.
9. Administration to elderly people
In general, elderly people have reduced physiological function, so they should be careful about reducing their intake.
10. Effect on clinical test values
1) It may interfere with the detection of urine sugar.
2) Various urinalysis (occult blood, bilirubin, nitrite) and fecal occult blood reaction tests may show false negative reactions.
3) It may turn urine yellow and affect clinical test values.
11. Application precautions
1) Injections containing this medicine should be used immediately.
2) Use immediately after opening and do not use anything left after use. Also, discard the used container.
3) Be careful when mixing as decomposition of vitamins may be accelerated.
4) Vitamins A, D, and riboflavin are sensitive to light, so minimize exposure to light, such as by using a light blocking cover.
5) Do not inject the undiluted solution as it may cause dizziness or fainting.
6) If mixed in protein amino acid preparation (transfusion solution), use within 8 hours.
12. Precautions for storage and handling
1) Store out of reach of children.
2) Avoid freezing and store in a cool place, protected from light.
3) Taking medicine out of its original container and storing it in another container may cause accidents due to misuse of the medicine or cause a decrease in the quality of the medicine, so put it in the original container and keep it tightly closed.
5. How to save
Sealed container, stored at room temperature (1~30℃)
6. Packaging unit
10 vials/case
7. Period of use
36 months from date of manufacture